Publisher: O’Neill Institute for National & Global Health Law
The Global Fund to Fight AIDS, Tuberculosis and Malaria has proven highly effective at fighting the world’s major killers. Strong governance and development institutions, however, are necessary for improving health long-term. While some suggest international aid can strengthen institutions, others worry “dead” aid undermines governance. The Fund is a unique aid institution with mechanisms designed to improve transparency and accountability. We constructed a unique dataset to explore whether Global Fund financing has a significant effect on governance and development.
Several GFAN Speakers participated in the Preparatory Meeting for the Global Fund’s Sixth Replenishment in India earlier this month. The participating Speakers: Maurine Murenga , Timur Abdullaev , Resty Nalwanga , and Erika Castellanos all had different roles during the meeting. With Timur speaking on a panel on sustainable financing for health, Erika speaking to attendees about mobilizing communities and young people to end the epidemics and achieve Sustainable Development Goals, and both Maurine and Erika participating as part of their roles as Board Member and Alternate Board Member for the Communities Delegation to the Global Fund. Finally, Resty addressed the Global Fund Board and guests to share her story and to highlight the importance of the Global Fund.
Resty was kind enough to share with us her speech.
On 11 January 2019 the Global Fund released a summary of their Investment Case which will be released in full in the next few weeks. We shared our concern with the numbers presented and that the $US14 billion funding target set for the Global Fund’s Sixth Replenishment will not be enough. This target is significantly lower than the need calculated in our Get Back On Track Report published in July 2018 in which we made a strong case for significant increases in funding to the Global Fund with a replenishment target of US$16.8 to 18 billion.
Matthew Kavanagh (HealthGap US and Georgetown U Visiting Professor & Director, Global Health Policy & Governance Initiative at the O’Neill Institute for National and Global Health Law) published the thread below and his analysis echoed some of our concerns with the US$ 14 billion ask.
We worked with Matt to delve into the details and source the data:
GFAN Statement on the Global Fund Investment Case Announcement
GFAN and its members welcome the Global Fund’s Investment Case summary released today in France by President Macron for its clear articulation that we are not yet on track to reach the targets of ending the three diseases by 2030 and that we must significantly step up our response to get back on track.
We are however concerned that the $US14 billion funding target set for the Global Fund’s Sixth Replenishment will not be enough to achieve this vital task. This target is significantly lower than the need calculated in our Get Back On Track Report published in July 2018 in which we made a strong case for significant increases in funding to the Global Fund with a replenishment target of US$16.8 to 18 billion.
We remain concerned that with foreign exchange fluctuations and changes in pricing, that this is barely more than a m...
GFAN members Friends of the Global Fund Europe and Osservatorio AiDS, in collaboration with AIDOS, and the theatre company Bluestocking, launched, earlier this month, a short video highlighting the most common stereotypes on HIV/AIDS in Italy. The video uses ironic messages to shape the audiences’ understanding of the portrayed clichés and highlight the critical role of the Global Fund in addressing the global reach of AIDS. Many of the stereotypes portrayed in the video are common in other countries and they wanted to share a version with English subtitles of their video .
The video was initially launched in Italy on World AIDS Day. Two similar videos on tuberculosis and malaria will be released in the upcoming months.
The video is part of a joint information campaign to make the Global Fund better known in Italy ahead of the next replenishment.